Arcadia Biosciences, Inc.·4

May 30, 6:24 PM ET

Jacot Stanley Jr 4

4 · Arcadia Biosciences, Inc. · Filed May 30, 2023

Insider Transaction Report

Form 4
Period: 2023-05-30
Jacot Stanley Jr
Chief Executive Officer
Transactions
  • Purchase

    Common stock

    2023-05-30$4.31/sh+5,000$21,5505,000 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION